Press Release
The PolkaStar—From the “Planet” Trade to the “Galaxy” Trade
Half a year after the Polkadot mainnet was launched, known as the “Ethereum Killer,” it immediately ranked among the top ten cryptocurrencies by market capitalization. Its unparalleled capital and technical strength have not only been recognized by developers from all walks of life, but also by investors. Favored, the market reacted strongly. Previously, many industry experts at home and abroad have successively published a lot of opinions on the development direction of blockchain. Among them, there are three points about the summary of cross-chain technology, namely “blockchain interoperability”, “ease of use” and ” Scalability”.

As DeFi (decentralized finance) has exploded from Ethereum with a market value of up to 20 billion U.S. dollars since 2020, and recently BTC has risen to 30,000 U.S. dollars, these three mountains make people urgently need a mature Cross-chain technology, because the market value of DeFi almost only exists in Ethereum, and BTC, which accounts for 66% of the total market value of the blockchain, cannot release its huge vitality.
If we want to connect all the public chains together, instead of isolated islands of information, the hidden wealth behind it can only be exploited with the help of mature cross-chain technology.
Fortunately, in the second half of 2020, the Polkadot ecosystem led by Ethereum co-founder Gavin Wood has made great progress. The 100-parachain 1000-person verification plan has been completed by 70%, and the Polkadot system has 1.02 billion. DOT is worth about 6 billion U.S. dollars, of which about 3.7 billion U.S. dollars have been staking. In just 6 months, Polkadot has become the largest network pledged by capital value.
Perhaps we can cheer, the real cross-chain era is finally here!
Based on the cross-chain consensus NPOS mechanism, the PolkaStar development team from the United States has embarked on the path of being a strong man from the beginning. When other aggregators are still struggling to find prey on a public chain, they have a rich blockchain PolkaStar, which has experience in investment management, has focused on several public chains and made full use of Polkadot’s native interoperability, which is the most basic structure for arbitrage.
Among all the current blockchains, only PolkaStar has started the aggregation arbitrage on polkadot. Through the parallel chain design, communication coordination, transaction and authentication management are carried out simultaneously to achieve rapid arbitrage.
This is like, from the begining, people can only do business on one planet, and now they can do business on multiple planets without limit. Not only the market has become bigger, the products have increased, and the trade volume has also increased exponentially. The significance of this for ordinary investors is that they can get the maximum profit through an optimal investment portfolio as much as possible.
From a functional point of view, the financial products on the parachain will be the core role of the Polkadot ecology, mainly creating various financial products to enrich the Polkadot ecology and increase the value of the blockchain network, while the fisherman of the PolkaStar is responsible for monitoring the new According to the conditions and constraints of the contract, the most suitable product is selected for nomination, and finally the data is integrated into arbitrage after verification by the smart contract.
The development team of PolkaStar believes that the blockchain should not be a financial game for the minority and elites, but an inclusive finance with the Internet of everything.
At present, there are many decentralized financial products that blockchain investors can choose. Take Staking as an example. Ordinary investors must first reach a higher threshold to participate, and they will often not be able to achieve the best price in subsequent operations. Or the lowest slippage can get more profits, and in the current blockchain world, not only the pledge yield is very low (as low as 4.9%), frequent operations also exploit the income due to the pledger, transaction fees, gas fees, etc. The decrease in value flow caused by it is also the loss of the pledger, which urgently needs a “network” that produces an optimization effect.
So, can the world’s first low-value pledged, automatic interest-bearing PolkaStar cross-chain aggregator change the current situation of investment difficulties and slow financial management for ordinary investors?
Up to now, the number of projects deployed in the Polkadot network is about to reach 300. As the star DeF project among them, PolkaStar has built a complete DeFi operating system based on Polkadot’s Substrate framework. The homogeneous parallel chains in the Polkadot ecosystem can be Directly access the DeFi application in the PolkaStar system, and support PolkaStar’s affiliate tokens and financial primitives through the XCMP inter-chain communication protocol, providing users with more investment opportunities and maximizing the savings income based on the PolkaStar stablecoin.
According to the PolkaStar developer, by connecting to the Polkadot network to become a parachain, the design of the parachain has further improved operational efficiency, improved cross-chain communication problems, and provided investors with more financial project solutions on the chain. Improve operability, so as to obtain more and faster arbitrage opportunities.
PolkaStar aims to provide users with the best source of liquidity. The partnership with the Polkadot ecosystem can accelerate the realization of this goal. Once the PolkaStar-Ethereum bridge is activated, DeFi users will be able to take advantage of PolkaStar’s fast transaction speed and lower The gas cost to complete the transaction.
PolkaStar can be regarded as a fund management company in the traditional financial market. The traditional fund team makes portfolio investment through human judgment to obtain income, while PolkaStar replaces the centralized management team through smart contracts, which is decentralized. In cross-chain financial products, the best and most suitable points are constantly searched for transactions to expand the income, and the income obtained is then distributed to participating investors according to the distribution principle.
PolkaStar uses the fully modular and flexible Substrate tool to mix and match off-the-shelf components and build core business logic, while the rest is left to the framework, which can realize direct communication arbitrage between different blockchains, which is equivalent to entering from a local area network With the Internet, different individuals and regions can be connected to each other until all individuals are connected together, which greatly improves the efficiency of value transfer and truly achieves inclusive finance.
Therefore, the entry threshold of PolkaStar is much lower than that of ordinary DeFi, and the operation is more close to the people. Through PolkaStar’s inter-chain communication scheduling, investors can automatically find the decentralized financial products with the highest yield through established smart contracts and participate in the acquisition of top mines. Profiteering. On the other hand, you can also enjoy the dividends of other chains brought by the PolkaStar cross-chain mechanism, which ensures that the system can discover the process of quickly obtaining arbitrage opportunities in time and strive for more profits for users.
PolkaStar allows rapid information transmission and communication between all parachains. The PolkaStar Communication Bridge monitors the information transmission between all parachains and obtains the fastest prompt; automatic pledge to quickly occupy and pledge the defi project, in fast arbitrage circulation of first ore between each parallel chain. Let the value be realized quickly.
From the perspective of ease of use, in the entire aggregation system, PolkaStar’s main supervision and control object is the financial products on the parachain. These various financial products are used to enrich the Polkadot ecology and increase the value of the blockchain network. The PolkaStar will form an automated financial system that monitors the operation of the latest DeFi system on all chains, communicates and dispatches directly at the right time, and the smart contract will automatically seize the first mining opportunity and automatically carry out mining arbitrage under preset conditions. Use the fastest speed and trading strategy to obtain profits in various DeFi projects.
All of these are circulated on a transparent chain. PolkaStar has built a complete positive circulation system to enable more and more people to participate. The more cross-chain financial networks that PolkaStar enables, such as cross-chain lending and transactions. The more DAPPs such as, liquidity mining, synthetic assets, futures, options, etc. run, the robustness and arbitrage space of the network will be better and greater. This is the guarantee of the prosperity of the entire PolkaStar system, and at the same time fast The network and arbitrage space also ensure the continuous and stable growth of the entire system.
2021 is meant to be the year of cross-chain domination!
The founder of Polkadot hopes to create a more general and abstract model to solve some of the problems in the blockchain industry, with the goal of “Make blockchain great again”. The vision of PolkaStar, which has advantages in technology and ideas, is: “Let blockchain finance radiate vitality!
The first step is PolkaStar to build a decentralized aggregate DeFi arbitrage system, and quickly establish a cross-chain DeFi mortgage interest generation, arbitrage monitoring, and income settlement system.
The Polkadot Galaxy will bring the interoperability of the network to a new level. It will be a brand new cross-chain operating system that supports the cross-chain interaction of other chain DAPP projects. By aggregating various decentralized financial derivatives, it provides a complete operating platform for the entire blockchain network. And create a new ecology. Become a new way of expressing the value flow of blockchain.
As ordinary investment and financial planners and blockchain practitioners, we can also look forward to the different things that PolkaStar developed based on cross-chain technology can bring, so that everyone has the opportunity to participate in the blockchain. From the ordinary “planet” trade expand to the “galaxy” trade, and finally achieve the real inclusive finance!
About Author
Disclaimer: The views, suggestions, and opinions expressed here are the sole responsibility of the experts. No Digi Observer journalist was involved in the writing and production of this article.
Press Release
ForexBrokers.Live: Simplifying MT4 and MT5 for Forex Traders
Dubai, United Arab Emirates, 13th Mar 2026 – ForexBrokers.Live is changing the way traders approach MetaTrader 4 (MT4) and MetaTrader 5 (MT5) platforms. The platform provides forex traders with essential tools, expert insights, and comprehensive guides to make informed decisions when choosing between these popular trading platforms.
MT4 has long been the go-to platform for forex traders, valued for its simplicity and reliability. Meanwhile, MT5 takes trading to the next level, offering additional features for more advanced traders, such as access to a wider range of financial instruments and enhanced charting capabilities. ForexBrokers.Live is committed to helping traders understand these platforms and how they can be used to maximize success in the forex market.
Empowering Traders with Knowledge
ForexBrokers.Live provides easy-to-understand guides that break down the complexities of both MT4 and MT5. The platform doesn’t just explain how to download and set up these platforms, it also offers expert reviews, broker comparisons, and practical tips on using advanced tools effectively. Whether you’re a beginner or an experienced trader, ForexBrokers.Live ensures you have the resources to choose the right broker and platform.
Choosing the Right Broker
Selecting the right broker is as important as choosing the right platform. ForexBrokers.Live makes this process easier by comparing brokers that support MT4 and MT5, highlighting their unique features, spreads, execution speeds, and customer support. This helps traders find the best-suited broker for their needs.
The platform goes beyond platform usage to offer in-depth broker reviews, ensuring traders are well-equipped to navigate the forex market confidently. ForexBrokers.Live also regularly updates its content, so users always have the latest information on brokers and platform features.
Looking Forward
ForexBrokers.Live continues to evolve to meet the growing needs of the trading community. The platform plans to expand its content with more detailed guides, updated reviews, and new features designed to keep traders informed and ready for the market’s challenges.
About ForexBrokers.Live
ForexBrokers.Live is a dedicated resource for forex traders, offering comprehensive guides, expert reviews, and broker comparisons for MetaTrader 4 (MT4) and MetaTrader 5 (MT5). With a focus on clarity and practicality, ForexBrokers.Live helps traders of all levels make informed decisions and choose the best platforms and brokers for their needs.
Media Contact
Organization: ForexBrokers.Live
Contact Person: Manish
Website: https://forexbrokers.live
Email: Send Email
City: Dubai
Country:United Arab Emirates
Release id:42570
The post ForexBrokers.Live: Simplifying MT4 and MT5 for Forex Traders appeared first on King Newswire. This content is provided by a third-party source.. King Newswire makes no warranties or representations in connection with it. King Newswire is a press release distribution agency and does not endorse or verify the claims made in this release. If you have any complaints or copyright concerns related to this article, please contact the company listed in the ‘Media Contact’ section
About Author
Disclaimer: The views, suggestions, and opinions expressed here are the sole responsibility of the experts. No Digi Observer journalist was involved in the writing and production of this article.
Press Release
FS-Elliott to Be Featured on Now We Know with Steve Guttenberg Airing March 14 on CNBC
Export, PA, United States, 13th Mar 2026 – The upcoming episode of Now We Know! with Steve Guttenberg, airing March 14, 2026 at 1pm ET on CNBC will feature FS-Elliott, a company specializing in the design and manufacturing of high-performance centrifugal air and gas compressors.

The segment provides viewers with a behind-the-scenes look at the engineering and precision required to produce industrial equipment that supports manufacturing, energy production, and critical infrastructure worldwide. Through advanced technology and meticulous design, FS-Elliott’s compressors help power operations across a wide range of industries.

From reliability and efficiency to long-term performance, the episode highlights the role that specialized equipment plays in keeping industrial systems running smoothly.
By showcasing FS-Elliott’s work, Now We Know! sheds light on the often-unseen technologies that support modern industry. The series continues its mission to reveal the innovation and expertise behind the systems that drive everyday life.

About Now We Know!
Hosted by actor, author, and businessman, Steve Guttenberg, this unique platform inspires the next generation of knowledge seekers and viewers around the country. Each episode features up to four industry experts who provide their own unique perspective on the topic at hand via a 6-8–minute segment produced by our team, bringing a fresh look at interesting narratives, moderated by the one and only Steve Guttenberg.
Learn more at NowWeKnowTV.com

About FS-Elliott Co., LLC
FS-Elliott is a global leader in the engineering and manufacturing of oil-free, centrifugal air and gas compressors, with operations in over 90 countries. For over 60 years, FS-Elliott has combined a commitment to quality with advanced technology, enabling our customers to increase productivity and lower system operating costs. For more information, visit www.fs-elliott.com.
For more details, contact:
Now We Know! with Steve Guttenberg
(877) 546-9995
feature@nowweknowtv.com
SOURCE Now We Know! with Steve Guttenberg
All images courtesy of Now We Know! with Steve Guttenberg
Media Contact
Organization: Now We Know!with Steve Guttenberg
Contact Person: Media Relations
Website: https://nowweknowtv.com/
Email: Send Email
Contact Number: +18775469995
City: Export
State: PA
Country:United States
Release id:42579
The post FS-Elliott to Be Featured on Now We Know with Steve Guttenberg Airing March 14 on CNBC appeared first on King Newswire. This content is provided by a third-party source.. King Newswire makes no warranties or representations in connection with it. King Newswire is a press release distribution agency and does not endorse or verify the claims made in this release. If you have any complaints or copyright concerns related to this article, please contact the company listed in the ‘Media Contact’ section
About Author
Disclaimer: The views, suggestions, and opinions expressed here are the sole responsibility of the experts. No Digi Observer journalist was involved in the writing and production of this article.
Press Release
CMS (867.HK/8A8.SG) : New Drug for Renal Anaemia Desidustat Tablets Approved in China
SHENZHEN, CHINA – China Medical System Holdings Limited (“CMS”, or the “Group”) is pleased to announce that on 13 March 2026, new drug for renal anaemia Desidustat Tablets (the “Product”) has been approved for marketing in China by the National Medical Products Administration of the People’s Republic of China (NMPA). The Product is a novel, oral HypoxiaInducible Factor-Prolyl Hydroxylase Inhibitor (HIF-PHI) for treating anaemia in non-dialysis adult, Chronic Kidney Disease (CKD) patients.
The approval of Desidustat Tablets will further strengthen the Group’s overall layout in the field of nephrology, and synergize with the marketed innovative drug Velphoro (Sucroferric Oxyhydroxide Chewable Tablets, indicated for CKD hyperphosphatemia). Through the efficient linkage of nephrology expert resources and channel networks, the Group is expected to rapidly promote the large-scale clinical application of Desidustat Tablets, providing differentiated treatment options for Chinese CKD patients with renal anaemia and making a positive contribution to the Group’s performance.
More information about Desidustat Tablets and Renal Anaemia
As a novel oral HIF-PHI, the Product’s mechanism of action promotes erythropoiesis through increasing endogenous erythropoietin, improving iron availability and reducing hepcidin. Its China Phase III clinical trial has demonstrated positive results. The primary endpoint of the haemoglobin (Hb) mean change from baseline to Week 7-9 has indicated that, Desidustat is more effective than placebo in increasing Hb level. Results from the extension study demonstrate that the Product can maintain Hb level within the target range over the long term with acceptable safety. In addition, the Product significantly reduces hepcidin levels and ameliorates iron metabolism disorders.
There is still a large unmet need in the treatment of anaemia in CKD patients in China. It is estimated that there are more than 120 million CKD patients in China[1]. Anaemia is one of the frequent complications of CKD, which exhibits a progressively increasing incidence with disease progression. A survey in China showed that the prevalences of anaemia in patients at CKD stage 1 to 5 were 22.0%, 37.0%, 45.4%, 85.1%, and 98.2%, respectively[2]. The target-achieving rate (the Hb level reaching the target value (110~120g / L)) has increased to 51.5% for haemodialysis CKD patients with anaemia[3], but is still only 8.2% for anaemia patients in non-dialysis CKD[4]. The Product is administrated orally, thus expecting to improve the treatment compliance of patients and to meet the unmet treatment needs in the field of CKD anaemia.
Desidustat Tablets have been approved for marketing in India.
CMS INTERNATIONAL DEVELOPMENT AND MANAGEMENT LIMITED, a wholly-owned subsidiary of the Group, obtained an exclusive license for the Product from Zydus Lifesciences Limited (earlier known as Cadila Healthcare Limited) pursuant to a License Agreement with an effective date of 20 January 2020.
The Group adheres to its core strategy of “innovation-driven”, having established a tiered and multi-dimensional innovation product portfolio with abundant reserves: 7 new drugs have been approved for marketing, 6 are currently under marketing review, and nearly 20 projects are about to initiate or are progressing through clinical trials. Through a dual-engine innovation approach combining collaborative development and in-house R&D, the Group continuously enriches its innovative pipeline centered on first-in-class (FIC) and best-in-class (BIC) products, efficiently advancing clinical development and commercialization. Moving forward, CMS will remain clinical needs-driven to deliver more quality pharmaceutical solutions, steadfastly advancing toward the goal of becoming a specialty-focused, innovation-excellent multinational pharmaceutical enterprise.
About CMS
CMS is a platform company linking pharmaceutical innovation and commercialization with strong product lifecycle management capability, dedicated to providing competitive products and services to meet unmet medical needs.
CMS focuses on the global first-in-class (FIC) and best-in-class (BIC) innovative products, and efficiently promotes the clinical research, development and commercialization of innovative products, enabling the continuous transformation of scientific research into clinical practices to benefit patients.
CMS deeply engages in several specialty therapeutic fields, and has developed proven commercialization capabilities, extensive networks and expert resources, resulting in leading academic and market positions for its major marketed products. CMS continues to promote the in-depth development in its advantageous specialty fields, strengthening the competitiveness of the Cardiovascular-Kidney-Metabolic/ gastroenterology/ ophthalmology/ skin health businesses, bringing economies of scale in specialty fields. Among them, the skin health business (Dermavon) has become a leading enterprise in its field, and is proposed to be listed independently on the SEHK. Meanwhile, CMS continuously promotes the operation and development of its integrated R&D, manufacturing and commercialization chain in Southeast Asia and the Middle East, capturing growth opportunities in emerging markets to support the high-quality and sustainable development of the Group.
Reference
1. ZhangL, WangF, WangL, et al. Prevalence of chronic kidney disease in China: a cross-sectional survey[J]. Lancet, 2012, 379(9818):815-822. DOI: 10.1016/S0140-6736(12)60033-6
2. Chinese Expert Consensus on the Diagnosis and Treatment of Renal Anemia (2014 Revised Edition)[J]. Chinese Journal of Nephrology, 2014, 30(9): 712-716. DOI: 10.3760/cma.j.issn.1001-7097.2014.09.015
3. 19th CSN Critical Care & Blood Purification Congress, Chinese Medical Association (July 2-5, 2025)
4. Chinese Expert Consensus on the Diagnosis and Treatment of Renal Anemia (2018 Revised Edition)[J]. Chinese Journal of Nephrology, 2018, 34(11): 860-866. DOI: 10.3760/cma.j.issn.1001-7097.2018.11.012
CMS Disclaimer and Forward-Looking Statements
This press release is not intended to promote any products to you and is not for advertising purposes. This press release does not recommend any drugs, medical devices and/or indications. If you want to know more about the diagnosis and treatment of specific diseases, please follow the opinions or guidance of your doctor or other medical and health professionals. Any treatment-related decisions made by healthcare professionals should be based on the patient’s specific circumstances and in accordance with the drug package insert.
This press release which has been prepared by CMS does not constitute any offer or invitation to purchase or subscribe for any securities, and shall not form the basis for or be relied on in connection with any contract or binding commitment whatsoever. This press release has been prepared by CMS based on information and data which it considers reliable, but CMS makes no representation or warranty, express or implied, whatsoever, and no reliance shall be placed on, the truth, accuracy, completeness, fairness and reasonableness of the contents of this press release. Certain matters discussed in this press release may contain statements regarding the Group’s market opportunity and business prospects that are individually and collectively forward-looking statements. Such forward-looking statements are not guarantees of future performance and are subject to known and unknown risks, uncertainties and assumptions that are difficult to predict. Any forward-looking statements and projections made by third parties included in this press release are not adopted by the Group and the Company is not responsible for such third-party statements and projections.
Media Contact
Brand: China Medical System Holdings Ltd.
Contact: CMS Investor Relations
Website: https://web.cms.net.cn/en/home/
About Author
Disclaimer: The views, suggestions, and opinions expressed here are the sole responsibility of the experts. No Digi Observer journalist was involved in the writing and production of this article.
-
Press Release7 days ago
Tony Swantek Expands His Entrepreneurial Legacy Across Finance, Blockchain, and National Business Services
-
Press Release1 week ago
CVMR and BITEC Establish Joint Venture CVMR R.D. Congo S.A.R.L. to Advance Exploration and In-Country Refining of Strategic Minerals
-
Press Release1 week ago
Cancos Tile and Stone Introduces the CTS Pro plus Collection: A New Professional-Grade Porcelain Tile Series Designed for Builders, Contractors, and Designers
-
Press Release7 days ago
Usethebitcoin (UTB) Strengthens Position as a Leading Guide for Sending Crypto Remittances Globally
-
Press Release6 days ago
Techysquad Highlights Shift Toward Long-Term SEO to Combat Rising Customer Acquisition Costs
-
Press Release1 week ago
Sonoma Manufactured Homes Expands Turnkey Small Home and ADU Installation Services Across Sonoma County
-
Press Release1 week ago
Industry Disruption – IKAPE Unveils K2 PRO Defining Professional Standards for the Mobile Cafe
-
Press Release7 days ago
Indian Contemporary Artist Gautam Mazumdar Stranded in Dubai Amid Escalating War Tensions
